Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations

被引:0
|
作者
Thomas Glaab
Claus Vogelmeier
Roland Buhl
机构
[1] University Hospital,Pulmonary Department
[2] Johannes Gutenberg-University,Department of Pneumology
[3] University Hospital Giessen and Marburg,undefined
来源
Respiratory Research | / 11卷
关键词
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Exercise Capacity; Functional Residual Capacity; Severe Chronic Obstructive Pulmonary Disease;
D O I
暂无
中图分类号
学科分类号
摘要
Current methods for assessing clinical outcomes in COPD mainly rely on physiological tests combined with the use of questionnaires. The present review considers commonly used outcome measures such as lung function, health status, exercise capacity and physical activity, dyspnoea, exacerbations, the multi-dimensional BODE score, and mortality. Based on current published data, we provide a concise overview of the principles, strengths and weaknesses, and discuss open questions related to each methodology. Reviewed is the current set of markers for measuring clinically relevant outcomes with particular emphasis on their limitations and opportunities that should be recognized when assessing and interpreting their use in clinical trials of COPD.
引用
收藏
相关论文
共 50 条
  • [41] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
    Nicholas W Morrell
    Matthew A Higham
    Peter G Phillips
    B Haleema Shakur
    Paul J Robinson
    Ray J Beddoes
    Respiratory Research, 6
  • [42] Physical activity in chronic obstructive pulmonary disease: Is it a process or an outcome?
    Benton, Melissa J.
    RESPIROLOGY, 2014, 19 (03) : 298 - 299
  • [43] Cryptogenic Hemoptysis in Chronic Obstructive Pulmonary Disease: Characteristics and Outcome
    Delage, Antoine
    Tillie-Leblond, Isabelle
    Cavestri, Beatrice
    Wallaert, Benoit
    Marquette, Charles-Hugo
    RESPIRATION, 2010, 80 (05) : 387 - 392
  • [44] Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease
    Angeliki M. Tsimogianni
    Spyros A. Papiris
    Georgios T. Stathopoulos
    Effrosyni D. Manali
    Charis Roussos
    Anastasia Kotanidou
    Journal of General Internal Medicine, 2009, 24 : 1043 - 1048
  • [45] New Modalities of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
    Martijn A. Spruit
    Emiel F. M. Wouters
    Sports Medicine, 2007, 37 : 501 - 518
  • [46] IndacaterolIn Chronic Obstructive Pulmonary Disease
    Marit D. Moen
    Drugs, 2010, 70 : 2269 - 2280
  • [47] Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease
    Tsimogianni, Angeliki M.
    Papiris, Spyros A.
    Stathopoulos, Georgios T.
    Manali, Effrosyni D.
    Roussos, Charis
    Kotanidou, Anastasia
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (09) : 1043 - 1048
  • [48] AclidiniumIn Chronic Obstructive Pulmonary Disease
    James E. Frampton
    Drugs, 2012, 72 : 1999 - 2011
  • [49] Prioritizing chronic obstructive pulmonary disease (COPD) candidate genes in COPD-related networks
    Zhang, Yihua
    Li, Wan
    Feng, Yuyan
    Guo, Shanshan
    Zhao, Xilei
    Wang, Yahui
    He, Yuehan
    He, Weiming
    Chen, Lina
    ONCOTARGET, 2017, 8 (61) : 103375 - 103384
  • [50] Echocardiographic predictors of outcome in patients with chronic obstructive pulmonary disease
    Stankovic, Ivan
    Marcun, Robert
    Janicijevic, Aleksandra
    Farkas, Jerneja
    Kadivec, Sasa
    Ilic, Ivan
    Neskovic, Aleksandar N.
    Lainscak, Mitja
    JOURNAL OF CLINICAL ULTRASOUND, 2017, 45 (04) : 211 - 221